Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Natural killer cells and hepatitis C: action and reaction.

Cheent K, Khakoo SI.

Gut. 2011 Feb;60(2):268-78. doi: 10.1136/gut.2010.212555. Epub 2010 Sep 28. Review.

PMID:
20876777
2.

Natural killer cells: primary target for hepatitis C virus immune evasion strategies?

Golden-Mason L, Rosen HR.

Liver Transpl. 2006 Mar;12(3):363-72. Review.

3.

Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.

Rosen HR.

Liver Transpl. 2003 Nov;9(11):S35-43. Review.

4.

Natural killer cells in viral hepatitis: facts and controversies.

Mondelli MU, Varchetta S, Oliviero B.

Eur J Clin Invest. 2010 Sep;40(9):851-63. doi: 10.1111/j.1365-2362.2010.02332.x. Epub 2010 Jun 29. Review.

PMID:
20597961
5.

NK cells prevalence, subsets and function in viral hepatitis C.

Zeromski J, Mozer-Lisewska I, Kaczmarek M, Kowala-Piaskowska A, Sikora J.

Arch Immunol Ther Exp (Warsz). 2011 Dec;59(6):449-55. doi: 10.1007/s00005-011-0145-y. Epub 2011 Oct 5. Review.

PMID:
21972016
6.

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.

Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.

J Immunol. 2009 Nov 15;183(10):6612-8. doi: 10.4049/jimmunol.0901437. Epub 2009 Oct 21.

7.

Pathogenesis, diagnosis and management of hepatitis C.

Boyer N, Marcellin P.

J Hepatol. 2000;32(1 Suppl):98-112. Review.

PMID:
10728798
8.

Immunology of hepatitis B and hepatitis C virus infections.

Boonstra A, Woltman AM, Janssen HL.

Best Pract Res Clin Gastroenterol. 2008;22(6):1049-61. doi: 10.1016/j.bpg.2008.11.015. Review.

PMID:
19187866
9.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

10.

Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.

Baumert TF, Wellnitz S, Aono S, Satoi J, Herion D, Tilman Gerlach J, Pape GR, Lau JY, Hoofnagle JH, Blum HE, Liang TJ.

Hepatology. 2000 Sep;32(3):610-7.

PMID:
10960457
11.

Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.

Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, Degott C, Aupérin A, Collins M, Kolberg J, Wilber J, Benhamou JP, Erlinger S.

Ann Intern Med. 1997 Jun 1;126(11):874-81.

PMID:
9163288
12.

The immunopathogenesis of hepatitis C virus infection.

Nelson DR.

Clin Liver Dis. 2001 Nov;5(4):931-53. Review.

PMID:
11685802
13.

The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.

Salem ML, El-Demellawy M, El-Azm AR.

Cell Immunol. 2010;262(2):96-104. doi: 10.1016/j.cellimm.2010.03.002. Epub 2010 Mar 6. Review.

PMID:
20338549
14.

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.

Varchetta S, Oliviero B, Francesca Donato M, Agnelli F, Rigamonti C, Paudice E, Arosio E, Berra M, Rossi G, Tinelli C, Fagnoni FF, Colombo M, Mavilio D, Mondelli MU.

J Hepatol. 2009 Feb;50(2):314-22. doi: 10.1016/j.jhep.2008.10.018. Epub 2008 Nov 24.

PMID:
19070924
15.

Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.

Agrati C, Nisii C, Oliva A, D'Offizi G, Montesano C, Pucillo LP, Poccia F.

Arch Immunol Ther Exp (Warsz). 2002;50(5):307-16. Review.

PMID:
12455864
16.

Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.

Rosen HR, Doherty DG, Madrigal-Estebas L, O'Farrelly C, Golden-Mason L.

Liver Transpl. 2008 Jan;14(1):31-40.

17.

Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection.

Pham TN, King D, Macparland SA, McGrath JS, Reddy SB, Bursey FR, Michalak TI.

Gastroenterology. 2008 Mar;134(3):812-22. doi: 10.1053/j.gastro.2007.12.011. Epub 2007 Dec 14.

PMID:
18243182
18.

Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.

Hiroishi K, Ito T, Imawari M.

J Gastroenterol Hepatol. 2008 Oct;23(10):1473-82. doi: 10.1111/j.1440-1746.2008.05475.x. Epub 2008 Aug 28. Review.

PMID:
18761560
19.

NK cells in hepatitis C: role in disease susceptibility and therapy.

Lunemann S, Schlaphoff V, Cornberg M, Wedemeyer H.

Dig Dis. 2012;30 Suppl 1:48-54. doi: 10.1159/000341680. Epub 2012 Oct 11. Review.

PMID:
23075868
20.

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.

Ahmad A, Alvarez F.

J Leukoc Biol. 2004 Oct;76(4):743-59. Epub 2004 Jun 24. Review.

PMID:
15218054

Supplemental Content

Support Center